0:00:00ovarian cancer is important
0:00:02because it is the leading close off gynaecology kind of cancer
0:00:07deaths and the fifth leading cause of cancer related deaths among women
0:00:12most women present we've advanced disease mainly because the non specific nature of symptoms
0:00:19leads to diagnostic delays
0:00:21recent data have shown a fall in over and constant mortality rate in the u
0:00:26k
0:00:27but rate are still higher when compared to other european countries in the united states
0:00:33of america
0:00:34the outlook for women we've ovarian cancer remains pull with an overall five here survivor
0:00:41right off
0:00:43less than fifty percent large epidemiological studies have reported
0:00:47poor survival rates for vowel and consonant the uk when compared to other european countries
0:00:53australia and canada
0:00:56this is in spite of the uk having a lead role in both
0:01:01a research and training conducting many of the major trial was invited cancer research and
0:01:07being the first your first european country to implement
0:01:12full model kind ecological and quality training in addition surgeons in the u k that's
0:01:17a on average loehr surgical cited reduction rates in places with advanced ovarian cancer the
0:01:24aim of this review this to present
0:01:27an overview of clinical epidemiology for the filler ovarian cancer in the united kingdom
0:01:33with an emphasis on incidence mortality and survival rate trends over time trends by aids
0:01:39international comparisons and national and regional variation in survivor instance and mortality are presented in
0:01:49the context of a major reorganisation of cancer services
0:01:52that took place in the u k over ten years ago centralization of cancer services
0:01:58has meant that women with ovarian cancer now receive treatment is tested least cancer centres